StonvexLoading…
StonvexStonvexStonvexCore line items from MG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $195.68M | $169.03M | $724.02M | $542.57M | $347.02M |
Operating Income | Not available | $4.68M | $40.57M | $27.80M | $7.42M |
Net Income | Not available | $2.39M | $16.84M | $12.94M | $-169.00K |
EPS (Diluted) | $0.27 | $0.07 | $0.53 | $0.41 | $0.00 |
Total Assets | Not available | $572.67M | $578.78M | $596.26M | $571.04M |
Total Liabilities | Not available | $339.07M | $343.14M | $368.43M | $354.87M |
Cash & Equivalents | Not available | $24.99M | $28.01M | $27.80M | $19.96M |
Free Cash Flow OCF − CapEx | Not available | $-3.16M | $8.31M | $-17.69M | $-13.62M |
Shares Outstanding | Not available | 31.82M | 31.57M | 31.55M | 31.54M |